Ignite Creation Date:
2024-05-05 @ 5:08 PM
Last Modification Date:
2024-10-26 @ 9:28 AM
Study NCT ID:
NCT00396318
Status:
COMPLETED
Last Update Posted:
2011-04-27
First Post:
2006-11-02
Brief Title:
A Study of Tenecteplase for Restoration of Function in Dysfunctional Central Venous Catheters
Sponsor:
Genentech Inc
Organization:
Genentech Inc
Study Overview
Official Title:
A Phase III Open-Label Single-Arm Study of Tenecteplase for Restoration of Function in Dysfunctional Central Venous Catheters
Status:
COMPLETED
Status Verified Date:
2011-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
TROPICS 2
Brief Summary:
This was a Phase III open-label single-arm study that was conducted at 43 centers in the United States and Canada 251 adult and pediatric patients with dysfunctional central venous catheters CVCs were enrolled in the study and treated with one or two doses of tenecteplase
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None